David Steinberg
Stock Analyst at Jefferies
(2.83)
# 1,781
Out of 4,944 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $7.17 | +11.58% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $23.66 | +166.27% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $42.62 | -6.15% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $117.10 | +60.55% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $12.50 | -36.00% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $4.78 | +151.05% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $2.70 | +640.74% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $7.17
Upside: +11.58%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $23.66
Upside: +166.27%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $42.62
Upside: -6.15%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $117.10
Upside: +60.55%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $12.50
Upside: -36.00%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $4.78
Upside: +151.05%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.70
Upside: +640.74%